You are here

BioNxt Solutions Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
BNXT
CSE Index: 
Currency: 

BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

You are here

BioNxt Solutions Inc. (BNXT)

SEDAR Information

Company Info

Address
Suite 270 - 1820 Fir Street
Vancouver, BC V7Y 1G5
Canada
Phone
780-818-6422
Email
info@bionxt.com
Listing date
Wednesday, July 31, 2019
Transfer Agent
Computershare Investor Services Inc.

Capitalization

Issued & Outstanding: 
109519065
Reserved for Issuance: 
11777150

Bulletins

10/11/2022

2022-1114 - Name and Symbol Change - XPhyto Therapeutics Corp. (XPHY)

Le 10 novembre/November 2022

XPhyto Therapeutics Corp. (XPHY) has announced a name and symbol change to BioNxt Solutions Inc. (BNXT).